Inhalation of antiviral drugs to combat respiratory virus infections: broadening the horizon in times of pandemic pressure
R Heida - 2024 - research.rug.nl
The COVID-19 pandemic has underlined the threat that viral outbreaks can pose to human
health. Therefore, it is essential to have high-quality antiviral drugs available that can be …
health. Therefore, it is essential to have high-quality antiviral drugs available that can be …
Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities
N Nainwal - Pulmonary Pharmacology & Therapeutics, 2022 - Elsevier
Respiratory viral infections are the leading cause of death worldwide. The current pandemic
of coronavirus infection (COVID-19) challenged human beings for the treatment and …
of coronavirus infection (COVID-19) challenged human beings for the treatment and …
Antivirals and the potential benefits of orally inhaled drug administration in COVID-19 treatment
G Sahin, O Akbal-Dagistan, M Culha, A Erturk… - Journal of …, 2022 - Elsevier
Abstract Coronavirus Disease 2019 (COVID-19) pandemic has been on the agenda of
humanity for more than 2 years. In the meantime, the pandemic has caused economic …
humanity for more than 2 years. In the meantime, the pandemic has caused economic …
Inhaled therapy for COVID-19: considerations of drugs, formulations and devices
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent
responsible for the COVID-19 pandemic, has outspread at full tilt across the world. Although …
responsible for the COVID-19 pandemic, has outspread at full tilt across the world. Although …
Therapeutic potential of inhalable medications to combat coronavirus disease-2019
The recent outbreak of coronavirus disease-2019 (COVID-19) in Wuhan, China has rapidly
spread across the world. The swift development of this pandemic has been attributed to …
spread across the world. The swift development of this pandemic has been attributed to …
[PDF][PDF] Lung Delivery Systems to Optimize Pharmacotherapy of COVID-19: A Concise Review
MG Alrashedi, AG Alrashedi, AS Ali… - J. Pharm. Res. Int, 2021 - researchgate.net
Background: COVID-19 is an ongoing viral pandemic caused by the SARS-COV-2 virus.
Several drugs were repurposed for its management; however, most of these drugs were not …
Several drugs were repurposed for its management; however, most of these drugs were not …
Inhaled dry powder to treat respiratory infections
T Saha - 2024 - ourarchive.otago.ac.nz
Abstract Respiratory Infections SARS-CoV-2 COVID-19 Dry powder inhaler Repurposed
drugs Spray drying Anti-viral nti-microbial Anti-infective Anti-SARS-CoV-2 Cytotoxicity Drug …
drugs Spray drying Anti-viral nti-microbial Anti-infective Anti-SARS-CoV-2 Cytotoxicity Drug …
Recent advances in inhaled nanoformulations of vaccines and therapeutics targeting respiratory viral infections
With the rapid outbreak of respiratory viral infections, various biological (eg vaccines,
peptides, recombinant proteins, antibodies and genes) and antiviral agents (eg ribavirin …
peptides, recombinant proteins, antibodies and genes) and antiviral agents (eg ribavirin …
The in vivo antiviral efficacy of a novel inhalation drug candidate in a mouse treatment and post-exposure prophylaxis model
J Zhou, E Jørgensen, JP Christensen, MTD Le… - 2023 - Eur Respiratory Soc
Background: Hypochlorous acid (HOCl), which is produced endogenously by neutrophils
and other phagocytes, has shown efficacy against a wide range of pathogens in vitro. The …
and other phagocytes, has shown efficacy against a wide range of pathogens in vitro. The …
Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administration
Many of the current pandemic threats are caused by viruses that infect the respiratory tract.
Remarkably though, the majority of vaccines and antiviral drugs are administered via …
Remarkably though, the majority of vaccines and antiviral drugs are administered via …